Latest News

MHRA Consultation to reschedule Gabapentin and Pregabalin

Monday, January 29, 2018

The MHRA are currently carrying out a public consultation on how best to reschedule Gabapentin and Pregabalin under the Misuse of Drugs Regulations 2001, as a result of increasing safety concerns and deaths where these two drugs have been implicated. Their current preferred option is to reschedule to Schedule 3 with Safe Custody requirements. Whilst we agree something must be done, we are of the strong view that, given the volume of dispensing, it would not be feasible to keep these items in CD cabinets in community pharmacy. Additional cabinets would almost certainly have to be purchased, and we are aware of a number of premises where the space for installing any further safes is simply not available.

We have responded to the consultation to reschedule Gabapentin and Pregabalin, and would encourage our members to get involved as well – often the number of responses which contain the same message is an important factor when responses are being analysed.

If you need any further information, please contact Adam in the policy office.